We are live on ! Find out more
IBRX icon

ImmunityBio
IBRX

241 hedge funds and large institutions have $328M invested in ImmunityBio in 2025 Q2 according to their latest regulatory filings, with 61 funds opening new positions, 103 increasing their positions, 37 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

178% more repeat investments, than reductions

Existing positions increased: 103 | Existing positions reduced: 37

126% more first-time investments, than exits

New positions opened: 61 | Existing positions closed: 27

37% more capital invested

Capital invested by funds: $239M → $328M (+$88.5M)

15% more funds holding

Funds holding: 210 → 241 (+31)

4.74% more ownership

Funds ownership: 9.33% → 14.07% (+4.7%)

3% less call options, than puts

Call options by funds: $11.9M | Put options by funds: $12.2M

Holders
241
Holders Change
+31
Holders Change %
+14.76%
% of All Funds
3.17%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
61
Increased
103
Reduced
37
Closed
27
Calls
$11.9M
Puts
$12.2M
Net Calls
-$313K
Net Calls Change
+$5.37M

Top Buyers

Rank Fund Capital Flow
1
Bank of America
Bank of America
North Carolina
+$22.1M
2
AC
Armistice Capital
New York
+$20.9M
3
Jane Street
Jane Street
New York
+$20.4M
4
BlackRock
BlackRock
New York
+$12M
5
AC
AlphaCore Capital
California
+$8M

Top Sellers

Rank Fund Capital Flow
1
Verition Fund Management
Verition Fund Management
Connecticut
-$1.56M
2
Group One Trading
Group One Trading
Illinois
-$1.53M
3
HF
HRT Financial
New York
-$715K
4
UBS Group
UBS Group
Switzerland
-$666K
5
Citigroup
Citigroup
New York
-$612K
Name Holding Trade Value Shares
Change 		Change in
Stake
HI
251
Humankind Investments
New York
– -$33.7K -11,184 Closed
FDCDDQ
252
Federation des caisses Desjardins du Quebec
Quebec, Canada
– -$33.1K -11,000 Closed
Victory Capital Management
253
Victory Capital Management
Texas
– -$32.2K -10,707 Closed
SC
254
Slow Capital
California
– -$30.1K -10,000 Closed
WAG
255
Wiser Advisor Group
Arizona
– -$6.02K -2,000 Closed
ZRP
256
Zynergy Retirement Planning
New Jersey
– -$4.99K -1,950 Closed
CIAM
257
Caitong International Asset Management
Hong Kong
– -$5.39K -1,791 Closed
SW
258
SVB Wealth
Massachusetts
– -$5.36K -1,780 Closed
HCP
259
Hexagon Capital Partners
Arkansas
– -$3.01K -1,000 Closed
BIG
260
Brooklyn Investment Group
New York
– -$2.05K -680 Closed
FFA
261
Farther Finance Advisors
California
– -$1.28K -434 Closed
PFBT
262
Parkside Financial Bank & Trust
Missouri
– -$527 -175 Closed
CCM
263
Coldstream Capital Management
Washington
– -$253 -84 Closed
HWM
264
Hemington Wealth Management
Virginia
– -$202 -75 -89%
GFPC
265
Global Financial Private Client
Florida
– -$96 -32 Closed
SIC
266
SJS Investment Consulting
Ohio
– -$28 -9 Closed
C
267
Covestor
United Kingdom
– -$11 -4 -6%
7 8 9 10
11

IBRX Hedge Fund Activity: Q2 2025 in Review

241 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in ImmunityBio (IBRX) for Q2 2025, worth a combined $328M — up 37% from $239M a quarter earlier.

Buyers outnumbered sellers: 61 funds opened new IBRX positions and 27 closed out — a net gain of 34 holders — while 103 added to existing stakes and 37 trimmed.

The largest buyer was Bank of America, adding an estimated $22.1M. The largest seller was Verition Fund Management, cutting an estimated $1.56M.

  • 241 institutional investors held ImmunityBio (IBRX) as of Q2 2025, up from 210 in Q1 2025.
  • Funds reported $328M of ImmunityBio stock for Q2 2025, up 37% quarter-over-quarter.
  • 61 funds opened new ImmunityBio positions in Q2 2025 and 27 closed out, a net change of +34 holders.
  • The largest ImmunityBio buyer in Q2 2025 was Bank of America, an estimated $22.1M added.
  • The largest ImmunityBio seller in Q2 2025 was Verition Fund Management, an estimated $1.56M sold.

Based on aggregated 13F filings for Q2 2025.